Extracellular vesicles mediated gastric cancer immune response: tumor cell death or immune escape?

Shuo Yang,Shibo Wei,Fang Wei

DOI: https://doi.org/10.1038/s41419-024-06758-8

2024-05-30

Cell Death and Disease

Abstract:Gastric cancer (GC) is a major global health issue, being the fifth most prevalent cancer and the third highest contributor to cancer-related deaths. Although treatment strategies for GC have diversified, the prognosis for advanced GC remains poor. Hence, there is a critical need to explore new directions for GC treatment to enhance diagnosis, treatment, and patient prognosis. Extracellular vesicles (EVs) have emerged as key players in tumor development and progression. Different sources of EVs carry different molecules, resulting in distinct biological functions. For instance, tumor-derived EVs can promote tumor cell proliferation, alter the tumor microenvironment and immune response, while EVs derived from immune cells carry molecules that regulate immune function and possess tumor-killing capabilities. Numerous studies have demonstrated the crucial role of EVs in the development, immune escape, and immune microenvironment remodeling in GC. In this review, we discuss the role of GC-derived EVs in immune microenvironment remodeling and EVs derived from immune cells in GC development. Furthermore, we provide an overview of the potential uses of EVs in immunotherapy for GC.

cell biology

What problem does this paper attempt to address?

The paper attempts to address the role of extracellular vesicles (EVs) in the immune microenvironment remodeling in gastric cancer (GC) and how these vesicles mediate tumor cell death or immune evasion. Specifically, the paper focuses on the following aspects:

1. **Effects of Gastric Cancer Cell-Derived Extracellular Vesicles on Immune Cells**:
- **T Cells**: Studies have found that gastric cancer cell-derived extracellular vesicles can affect the function of CD8+ T cells, including inhibiting their proliferation, inducing apoptosis, and leading to T cell inactivation through PD-L1 and PD-1 interactions.
- **CD4+ T Cells**: Gastric cancer cell-derived extracellular vesicles can affect the number and function of CD4+ T cells, particularly by inhibiting their immune activity through PD-L1 expression.
- **Regulatory T Cells (Tregs)**: Gastric cancer cell-derived extracellular vesicles can promote the expansion of Tregs, thereby enhancing the immunosuppressive effect.
- **γδT Cells**: Gastric cancer cell-derived extracellular vesicles carry miR-135b-5p, affecting the function of Vγ9Vδ2 T cells, leading to a decrease in their anti-tumor capability.
- **Macrophages**: Gastric cancer cell-derived extracellular vesicles can induce macrophage polarization towards the M2 type, thereby promoting tumor progression and immune evasion.
- **Natural Killer Cells (NK Cells)**: Gastric cancer cell-derived extracellular vesicles can reduce the number of NK cells, forming an immunosuppressive microenvironment.
- **Myeloid-Derived Suppressor Cells (MDSCs)**: Gastric cancer cell-derived extracellular vesicles can promote the expansion and activation of MDSCs, further enhancing immunosuppression.

2. **Effects of Immune Cell-Derived Extracellular Vesicles on Gastric Cancer Cells**:
- **Macrophage and Dendritic Cell (DC)-Derived Extracellular Vesicles**: These vesicles can affect the immune response of gastric cancer cells and participate in immune regulation.

3. **Potential Applications of Extracellular Vesicles in Gastric Cancer Immunotherapy**:
- The paper also discusses the potential applications of extracellular vesicles in gastric cancer immunotherapy, including their possibilities as diagnostic markers, therapeutic agents, drug targets, and drug carriers.

In summary, the paper aims to explore the mechanisms of extracellular vesicles in the immune microenvironment of gastric cancer in depth, providing a theoretical basis for the further development of new diagnostic and therapeutic methods.